Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (FY)2025/04/30 | (FY)2024/04/30 | (Q4)2024/04/30 | (Q3)2024/01/31 | (Q2)2023/10/31 | (Q1)2023/07/31 | (FY)2023/04/30 | (Q4)2023/04/30 | (Q3)2023/01/31 | (Q2)2022/10/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 9.15%464.79億 | 7.35%425.81億 | 13.40%87.41億 | 7.56%172.66億 | 5.22%96.55億 | 2.82%69.19億 | 1.58%396.67億 | -6.71%77.08億 | 0.04%160.52億 | 4.77%91.77億 |
| 主營業務成本 | 11.34%349.82億 | 5.93%314.2億 | 17.16%70.22億 | 3.64%125.65億 | 2.13%68.73億 | 3.04%49.6億 | 3.59%296.6億 | -4.53%59.94億 | 4.21%121.23億 | 6.25%67.29億 |
| 毛利 | 3.01%114.97億 | 11.55%111.62億 | 0.27%17.19億 | 19.65%47.01億 | 13.69%27.83億 | 2.27%19.59億 | -3.96%100.06億 | -13.58%17.14億 | -10.97%39.29億 | 0.93%24.47億 |
| 營業費用 | 3.47%88億 | 9.66%85.05億 | 33.61%22.94億 | 3.44%24.55億 | -1.23%19.89億 | 6.98%17.66億 | 0.43%77.55億 | -18.13%17.17億 | 5.83%23.73億 | 8.20%20.14億 |
| 營業利潤 | 1.53%26.97億 | 18.03%26.57億 | -19,119.71%-5.75億 | 44.37%22.46億 | 83.00%7.94億 | -27.14%1.93億 | -16.54%22.51億 | 97.37%-299.4萬 | -28.32%15.56億 | -23.09%4.34億 |
| 營業外利息收入與支出淨額 | -37.40%-9,405.7萬 | -69.27%-6,845.4萬 | -2.07%-1,277.4萬 | -93.54%-2,005.9萬 | -117.41%-1,934.7萬 | -87.86%-1,627.4萬 | -19.04%-4,044.1萬 | -74.28%-1,251.5萬 | -0.28%-1,036.4萬 | 6.35%-889.9萬 |
| 營業外利息收入 | 391.67%5.9萬 | -55.56%1.2萬 | -75.00%4,000 | --0 | -27.27%8,000 | --0 | 68.75%2.7萬 | 60.00%1.6萬 | --0 | --1.1萬 |
| 營業外利息支出 | 37.46%9,411.6萬 | 69.19%6,846.6萬 | 1.97%1,277.8萬 | 93.54%2,005.9萬 | 117.23%1,935.5萬 | 87.86%1,627.4萬 | 19.07%4,046.8萬 | 74.26%1,253.1萬 | 0.28%1,036.4萬 | -6.29%891萬 |
| 投資淨收益 | 9.87%6,224.9萬 | 36.58%5,665.7萬 | 0.00%1.5萬 | 25.21%2,550.9萬 | 0.02%620.4萬 | 67.41%2,492.9萬 | 108.23%4,148.2萬 | 0.00%1.5萬 | 191.67%2,037.3萬 | 19.93%620.3萬 |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | -3,459.1萬 | 0 | ||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | -127.08%-961.5萬 | -41.34%3,550.2萬 | -79.47%1,446.8萬 | -16.21%-972.8萬 | 143.84%69.4萬 | 3,006.8萬 | 150.16%6,052.4萬 | 162.95%7,047.8萬 | -837.1萬 | -2,335.38%-158.3萬 |
| 減:其他特殊費用 | 87.27%-451.9萬 | 41.34%-3,550.2萬 | 79.47%-1,446.8萬 | 16.21%972.8萬 | ---69.4萬 | ---3,006.8萬 | -150.16%-6,052.4萬 | -162.95%-7,047.8萬 | --837.1萬 | ---- |
| 減:勾銷 | --1,413.4萬 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| 其他營業外收入(費用) | -23.58%2.79億 | 0.89%3.65億 | -29.40%6,039.5萬 | 68.69%1.2億 | -22.24%8,823.8萬 | 5.33%9,659.9萬 | 23.74%3.62億 | 87.51%8,554.1萬 | 5.78%7,090.7萬 | 8.37%1.13億 |
| 稅前利潤 | -4.76%29億 | 13.88%30.45億 | -465.30%-5.13億 | 45.02%23.61億 | 60.15%8.69億 | -9.50%3.28億 | -6.32%26.74億 | 174.96%1.41億 | -27.12%16.28億 | -18.27%5.43億 |
| 所得稅 | 26.88%9.51億 | -9.98%7.49億 | -747.13%-3.65億 | 44.27%7.51億 | 47.30%2.62億 | 30.05%1億 | -9.13%8.32億 | 245.54%5,636萬 | -26.22%5.21億 | -13.56%1.78億 |
| 除稅後利潤 | -15.09%19.49億 | 24.67%22.96億 | -276.57%-1.49億 | 45.38%16.1億 | 66.43%6.07億 | -20.19%2.28億 | -5.00%18.42億 | 156.58%8,416.6萬 | -27.54%11.07億 | -20.38%3.65億 |
| 持續經營利潤 | -15.09%19.49億 | 24.67%22.96億 | -276.57%-1.49億 | 45.38%16.1億 | 66.43%6.07億 | -20.19%2.28億 | -5.00%18.42億 | 156.58%8,416.6萬 | -27.54%11.07億 | -20.38%3.65億 |
| 歸屬于少數股東的淨利潤 | 0 | 0 | 0 | |||||||
| 歸屬於母公司的淨利潤 | -15.09%19.49億 | 24.67%22.96億 | -276.57%-1.49億 | 45.38%16.1億 | 66.43%6.07億 | -20.19%2.28億 | -5.00%18.42億 | 156.58%8,416.6萬 | -27.54%11.07億 | -20.38%3.65億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | -15.09%19.49億 | 24.67%22.96億 | -276.57%-1.49億 | 45.38%16.1億 | 66.43%6.07億 | -20.19%2.28億 | -5.00%18.42億 | 156.58%8,416.6萬 | -27.54%11.07億 | -20.38%3.65億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | -15.09%386.52 | 24.67%455.21 | -276.51%-29.46 | 45.37%319.15 | 66.44%120.35 | -20.19%45.17 | -5.00%365.14 | 156.60%16.69 | -27.53%219.54 | -20.38%72.31 |
| 稀釋每股收益 | -15.09%386.52 | 24.67%455.21 | -276.57%-29.4652 | 45.38%319.15 | 66.43%120.3449 | -20.19%45.17 | -5.00%365.14 | 156.58%16.6871 | -27.53%219.5333 | -20.38%72.31 |
| 每股派息 | 8.33%65 | 9.09%60 | 9.09%60 | 0 | 0 | 0 | 10.00%55 | 10.00%55 | 0 | 0 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |